Entrez medline Query

Other Formats: [Citation Format] [MEDLINE Format]
Links: [195 medline neighbors]

Order this document

Genetics 1995 Aug;140(4):1223-33

Construction and analysis of yeast RNA polymerase II CTD deletion and substitution mutations.

West ML, Corden JL

Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2185, USA.

The carboxyl-terminal domain (CTD) of the RNA polymerase II largest subunit plays an essential but poorly understood role in transcription. The CTD is highly phosphorylated in vivo and this modification may be important in the transition from transcription initiation to elongation. We report here the development of a strategy for creating novel yeast CTDs. We have used this approach to show that the minimum viable CTD in yeast contains eight consensus (Tyr1Ser2Pro3Thr4Ser5Pro6Ser7) heptapeptide repeats. Substitution of alanine or glutamate for serines in positions two or five is lethal. In addition, changing tyrosine in position one to phenylalanine is lethal. The effects of mutations that alter potential phosphorylation sites are consistent with a requirement for CTD phosphorylation in vivo.

PMID: 7498765, UI: 96120341


the above report in format
documents on this page through Loansome Doc